EY Report Suggests Improving Conditions for U.S. IPOs in 2018
U.S. IPO activity has been increasing, with 36 IPOs raising more than $12.7B so far this year according to EY, the global consulting and accounting firm. The number of first-quarter IPOs is 44% higher than the 25 offerings in the first quarter of 2017 and the $12.7B total raised was almost 17% higher than the $10.9B raised in the same quarter last year.
This is encouraging because the first quarter is usually the slowest period for IPO activity, said Tim Holl, an EY partner. He expects this activity to continue to ramp up in the second quarter, which in recent years has been the most-active quarter for U.S. IPO activity.
EY highlighted its expectations for IPOs in 2018, including the fact that interest in healthcare IPOs remains high. Holl noted that 11 of the first-quarter’s 36 IPOs were life science companies, including Menlo Therapeutics, Armo Biosciences, and Solid Biosciences.
